Francoise Simon, PhD
Professor Emerita, Columbia University
Senior Faculty, Mt. Sinai School of Medicine
Francoise Simon, PhD, is an internationally known author, speaker and consultant with recognized expertise in the digital transformation of healthcare. She is highly experienced in strategy consulting in the Americas, Europe, Asia and Africa, with clients including healthcare leaders, new venture firms, several governments and the United Nations. Dr. Simon’s book, Managing Biotechnology: From Science to Market in the Digital Age (Wiley), covers the new role of infotech in healthcare, and shows how to capitalize on digital technologies, from R&D to the market. New models and cases contributed by senior executives combine as a roadmap to best practices at each stage of a patient-centered, digitally enabled, value chain. Dr. Simon’s academic teaching focuses on executive programs. She also chairs symposia at major conferences, and she conducts industry seminars globally on digital business strategy, including disruptive innovation, customer experience, precision marketing, multi-channel communications and patient centric organization design.
Sandy has over twenty years of experience focused on digital transformation and the technology consulting space. She also teaches computer science with a specialty in emerging technology – robotics, artificial intelligence, drones and 3D printing. Before starting E426.org, Sandy served as Managing Partner and COO of Magic Hat Consulting and led emerging business and research at IBM Business Consulting Services. She is currently CEO of e426.org, an emerging technology thinktank to assist entrepreneurial companies with using new or evolving technology. In addition to her expertise in digital innovation, Sandy is also a licensed pilot and drone Pilot and is retired from the United States Air Force after 22 years as an air force leader and instructor pilot.
Founder and President, CP&P Development, LLC
An accomplished pharmaceutical operations executive, Gerald Mosely, PhD, helps leaders and their teams achieve business objectives by focusing on people-oriented leadership components that impact an organization. In his career of over twenty years in the pharmaceutical industry, he has experience in sales, marketing, and country management across multiple therapeutic areas, and he served as general manager and a medical science liaison. Leading commercial and technical teams with over 2,000 in headcount globally while managing US, ex-US and global P&L's, Gerald has also led organizational design, involving structure, standards, strategy as well as people, and has driven multiple product launches in different international markets.
President and Founder, Center for Communication Compliance
2014 HBA STAR
Ilyssa founded the Center for Communication Compliance (CCC) to help the life sciences industry save time and money and manage risk. She is an industry leader and expert spokesperson on compliant digital innovation. A published author and columnist on regulatory compliance, behavioral science and cross-functional collaboration, she was named one of the industry's 100 Inspiring People in 2012 by PharmaVOICEmagazine. Ilyssa held executive positions with Grey Global Group, successfully navigating several of the holding company’s healthcare practices for over two decades. In 2004, she identified an unmet need for a center like CCC focused on regulatory compliance learning to help clients innovate more efficiently in a complex, ever-changing landscape. Recognized as a futurist, Ilyssa invented unique compliance-related offerings that educate and optimize business impact for leading drug and medical device companies. She served as a corporate board member for the Healthcare Businesswomen’s Association (HBA) which honored Ilyssa with the HBA STAR in 2014 for her work in driving greater awareness about the business benefits of cross-functional collaboration throughout a product’s lifecycle.
Founder, H. L. Dorfman Pharmaceutical Consulting, LLC
Howard is an expert in FDA regulatory law, fraud and abuse, compliance programs, and risk management procedures. and provides compliance, regulatory and risk management consulting services to pharmaceutical and biotech companies and law firms. He is also the editor-in-chief and contributing author of the Practicing Law Institute’s Answer Book on Pharmaceutical Compliance and Enforcement and a Visiting Distinguished Professor at Seton Hall Law School. He has lectured and published articles on a range of legal and compliance issues pertaining to the pharmaceutical industry. Additionally, he has served as Senior Vice President and General Counsel at Turing Pharmaceuticals; Vice President and General Counsel at Ferring Pharmaceuticals, Inc.; and Vice President and Assistant General Counsel at Bayer Pharmaceuticals (U.S.).
President, Arbor Scientia
Richard is president and CEO of the Arbor Scientia Group, a global medical communications company headquartered in Carlsbad, California. He is also an author, speaker, consultant and executive coach. His experience with the pharmaceutical industry spans over 20 years and includes many clients, including AstraZeneca, Acadia, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, Johnson & Johnson, Lundbeck, Merck, Novartis, Ortho-McNeil, Otsuka, Pfizer, Sevier, Sunovion, Takeda, and Teva among others. His educational programs have been cited by the San Diego Branch of the American Psychiatric Association for excellence in medical education and by the CINP for post-graduate education in neurology and psychiatry. They have also been designated by the Accreditation Council for Continuing Medical Education (ACCME) for its highest designation, namely accreditation with commendation, for the Neuroscience Education Institute, where Mr. Davis consulted and worked prior to joining Arbor Scientia. Prior to his current role as founding president of Arbor Scientia, Mr. Davis specialized in management, leadership, culture change, communications, team building, and product launches for numerous industries as an independent consultant. His client list outside of the pharmaceutical industry includes Acura, BMW, Chevron Oil, Ford Motor, Honda, Lexus, Mercedes Benz, Office Depot, and Toyota. He was also the host of a series of television broadcasts seen in the U.S. and Canada dealing with customer satisfaction and negotiation.
Susan Winter, PhD
Dr. Winter is a nationally known expert in applying cognitive techniques to optimize stakeholder collaboration and solve complex business challenges. She leverages decades of experience with cognitive processes and skills training to help boost her clients’ workplace performance, converting unproductive attitudes and belief patterns held by those in diverse functions and in varied leadership positions into productive, solution-focused interactions. She helps companies manage conflict situations arising from diverse functional styles, skills, competencies and the interplay of personalities. Dr. Winter earned her PhD at the Albert Einstein College of Medicine at Yeshiva University, a premier, research-intensive medical school dedicated to innovative biomedical investigation.